APYX - Apyx Medical Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Revenue - 10,234 8,819 29,520
Cost of Revenue - 3,276 3,703 16,963
Gross Profit - 6,958 5,116 12,557
Operating Expenses
Research Development - 1,941 1,033 2,160
Selling General and Administrative - 17,378 15,475 17,383
Non Recurring - - - -
Others - - - -
Total Operating Expenses - 22,595 20,211 36,506
Operating Income or Loss - -12,361 -11,392 -6,986
Income from Continuing Operations
Total Other Income/Expenses Net - -1,477 -94 1,641
Earnings Before Interest and Taxes - -12,361 -11,392 -6,986
Interest Expense - -136 -158 -158
Income Before Tax - -13,838 -11,486 -5,345
Income Tax Expense - -156 64 25
Minority Interest - - - -
Net Income From Continuing Ops - -13,682 -11,550 -5,370
Non-recurring Events
Discontinued Operations - 8,620 7,600 7,600
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income - -5,062 -3,950 -5,370
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares - -5,062 -3,950 8,364